152 related articles for article (PubMed ID: 33283497)
21. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
Johari B; Zargan J
Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
[TBL] [Abstract][Full Text] [Related]
23. [Effects of nuclear factor of kappa B decoy oligodeoxynucleotides on murine with multiple myeloma].
Shi KH; Jiang HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):132-6. PubMed ID: 25687060
[TBL] [Abstract][Full Text] [Related]
24. CpG oligodeoxynucleotide-loaded PAMAM dendrimer-coated magnetic nanoparticles promote apoptosis in breast cancer cells.
Taghavi Pourianazar N; Gunduz U
Biomed Pharmacother; 2016 Mar; 78():81-91. PubMed ID: 26898428
[TBL] [Abstract][Full Text] [Related]
25. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
[TBL] [Abstract][Full Text] [Related]
26. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
[TBL] [Abstract][Full Text] [Related]
28. MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression.
Niu CS; Yang Y; Cheng CD
Int J Oncol; 2013 May; 42(5):1533-40. PubMed ID: 23467648
[TBL] [Abstract][Full Text] [Related]
29. Formulation, Characterization and
Patel P; Barot T; Kulkarni P
Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
[TBL] [Abstract][Full Text] [Related]
30. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
Mehta M; Paudel KR; Shukla SD; Allam VSRR; Kannaujiya VK; Panth N; Das A; Parihar VK; Chakraborty A; Ali MK; Jha NK; Xenaki D; Su QP; Wich PR; Adams J; Hansbro PM; Chellappan DK; Oliver BGG; Dua K
J Control Release; 2021 Sep; 337():629-644. PubMed ID: 34375688
[TBL] [Abstract][Full Text] [Related]
31. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
Osako MK; Nakagami H; Morishita R
Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
[TBL] [Abstract][Full Text] [Related]
32. Transfection of hypoxia-inducible factor-1 decoy oligodeoxynucleotides suppresses expression of vascular endothelial growth factor in oral squamous cell carcinoma cells.
Imai M; Ishibashi H; Nariai Y; Kanno T; Sekine J; Onimaru M; Mori Y
J Oral Pathol Med; 2012 Oct; 41(9):675-81. PubMed ID: 22582814
[TBL] [Abstract][Full Text] [Related]
33. Nanoarchitectonics of Multifunctional Niosomes for Advanced Drug Delivery.
Momekova DB; Gugleva VE; Petrov PD
ACS Omega; 2021 Dec; 6(49):33265-33273. PubMed ID: 34926878
[TBL] [Abstract][Full Text] [Related]
34. Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide.
Deng C; Zheng J; Wan W; Zhang S; Ding Z; Mao G; Yang S
Mol Med Rep; 2013 Mar; 7(3):785-90. PubMed ID: 23338822
[TBL] [Abstract][Full Text] [Related]
35. Arginine-tocopherol bioconjugated lipid vesicles for selective pTRAIL delivery and subsequent apoptosis induction in glioblastoma cells.
Ravula V; Lo YL; Wu YT; Chang CW; Patri SV; Wang LF
Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112189. PubMed ID: 34082988
[TBL] [Abstract][Full Text] [Related]
36. A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.
De Stefano D; Coletta C; Bianca Rd; Falcone L; d'Angelo I; Ungaro F; Quaglia F; Carnuccio R; Sorrentino R
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):288-95. PubMed ID: 23590300
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87.
Liu XL; Zhao D; Sun DP; Wang Y; Li Y; Qiu FQ; Ma P
J Exp Clin Cancer Res; 2012 Feb; 31(1):8. PubMed ID: 22293781
[TBL] [Abstract][Full Text] [Related]
39. Elucidating the Motif for CpG Oligonucleotide Binding to the Dendritic Cell Receptor DEC-205 Leads to Improved Adjuvants for Liver-Resident Memory.
Li J; Panetta F; O'Keeffe M; Leal Rojas IM; Radford KJ; Zhang JG; Fernandez-Ruiz D; Davey GM; Gully BS; Tullett KM; Rossjohn J; Berry R; Lee CN; Lahoud MH; Heath WR; Caminschi I
J Immunol; 2021 Oct; 207(7):1836-1847. PubMed ID: 34479944
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
